Invention Grant
- Patent Title: Etanercept formulations exhibiting marked reduction in sub-visible particles
-
Application No.: US14592569Application Date: 2015-01-08
-
Publication No.: US10822429B2Publication Date: 2020-11-03
- Inventor: Mark Manning , Brian Murphy , Douglas Farrar , Alan Herman
- Applicant: Coherus Biosciences, Inc.
- Applicant Address: US CA Redwood City
- Assignee: Coherus Biosciences, Inc.
- Current Assignee: Coherus Biosciences, Inc.
- Current Assignee Address: US CA Redwood City
- Agency: Rothwell, Figg, Ernst & Manbeck, P.C.
- Main IPC: C07K19/00
- IPC: C07K19/00 ; A61K38/17 ; A61K9/14 ; A61K47/02 ; A61K47/18 ; A61K47/22 ; A61K47/26 ; A61K47/34 ; C07K14/715 ; C07K16/24 ; A61K47/10 ; C07K14/705 ; A61K39/00
Abstract:
The invention provides stabilized aqueous pharmaceutical etanercept compositions suitable for long-term storage of etanercept, with substantial reduction in sub-visible particles, and methods of manufacture of these compositions, methods of administration, and articles of manufacture.
Public/Granted literature
- US20150125532A1 Etanercept Formulations Exhibiting Marked Reduction in Sub-Visible Particles Public/Granted day:2015-05-07
Information query
